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Abstract
Background: Calcium supplementation during pregnancy has been shown to reduce the incidence
of hypertension in the mother, but the effects on the offspring are uncertain. Assessing the impact
on the offspring is very important given the now large body of evidence indicating that blood
pressure levels in childhood and young adulthood can be influenced by factors operating during fetal
life. We conducted a systematic review of the literature to summarize the evidence supporting an
association between maternal dietary calcium intake during pregnancy and blood pressure in the
offspring.
Methods: A systematic review was performed to identify randomized, quasi-randomized and
cohort studies reporting the relationship between offspring blood pressure or incidence of
hypertension and levels of maternal dietary calcium intake during pregnancy, either from
supplements (i.e. pills) or food. MEDLINE, EMBASE and the Cochrane Library Registry were
searched for relevant trials.
Results: Two randomized trial and three observational studies were identified and included in this
review. In 4 of the 5 studies, loss to follow-up was a serious concern. There was heterogeneity
between the studies, particularly those conducted on children below 12 month of age. Results were
more consistent among the studies including older children (1 to 9 years) where a higher maternal
calcium intake was associated with a reduction of -1.92 mm Hg (95% CI -3.14 to -0.71) in offspring
systolic blood pressure. One large randomized trial found a clinically and statistically significant
reduction in the incidence of hypertension in 7-year-old children (RR = 0.59, 95% CI 0.39 to 0.90).
Conclusion: There is evidence in the literature to support an association between maternal
calcium intake during pregnancy and offspring blood pressure. However, more research is needed
to confirm these finding given the small sample sizes and the methodological problems in many of
the studies conducted so far. More studies on populations with calcium deficit are also needed. If
confirmed, these findings could have important public health implications. Calcium supplementation
during pregnancy is simple and inexpensive and may be a way to reduce the risk of hypertension
and its sequels in the next generation.
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Background
Increased dietary calcium intake has been associated with
lower blood pressure among children, adults and preg-
nant women [1,2]. The effect seems to be more evident
among individuals with low calcium intake [3-6]. Some
recent experimental and observational studies in humans
and animals have reported an association between mater-
nal calcium intake during pregnancy and blood pressure
in the offspring [5,6], but others have not [1,7]. These
findings follow a large body of evidence indicating that
blood pressure levels in childhood and young adulthood
are influenced by factors operating early in life [7-10] and
are associated with later cardiovascular disease and mor-
tality [11]. We conducted a systematic review and meta-
analysis of studies reporting blood pressure levels in off-
spring of mothers who were either enrolled in a trial of
calcium supplementation during pregnancy or included




This review includes randomized and quasi-randomized
controlled trials. We pre-specified that if the evidence
from randomized trials was insufficient (i.e. small trials,
trials of bad quality, etc.) to assess the effect of the inter-
vention, then data from observational studies (e.g. cohort
studies) would be considered for inclusion. Studies with
historical controls and ecological studies were excluded,
as the data provided by these are unreliable for determin-
ing causation and/or association.
Studies should provide an estimate of the incidence of
hypertension, or the mean difference in offspring blood
pressure between levels of maternal calcium dietary intake
during pregnancy, or should enable this information to be
computed from data extracted from the article.
Types of participants
Offspring of mothers included in studies assessing the
association between calcium intake during pregnancy and
offspring blood pressure.
Types of intervention or exposure
Maternal dietary calcium intake during pregnancy, from
supplements (i.e. pills) or food.
Types of outcome measures
Offspring diastolic and systolic blood pressure in mm Hg;
incidence of hypertension.
Search strategy for identification of studies
1. MEDLINE and EMBASE (1966 to 2005) were searched
in December 2005 using the following search strategy
#1 Search calcium [Title] 84110
#2 Search pregnan* 568541
#3 Search "blood pressure" 247471
#4 Search hyperten* 241702
#5 Search #1 AND #2 AND (#3 OR #4) 253
2. All databases included in The Cochrane Library (issue
4, 2005) were searched with a search strategy equivalent
to the Medline strategy.
3. Reference lists of all the studies that went into the pool
of retrieved studies, including those of other reviews, were
examined to identify any further studies. We did not
implement a standardized strategy to find unpublished
studies.
Selection of studies and data extraction
The titles, abstracts and descriptor terms of all material
downloaded from the electronic searches were read and
irrelevant reports were discarded. All citations identified
were then inspected to establish the relevance of the arti-
cle according to the inclusion criteria. Where there was
uncertainty about relevance, the full article was obtained.
Studies were reviewed for relevance on the basis of study
design, types of participants, exposures and outcome
measures. Standardized data extraction forms were used,
one for clinical trials and one for cohort/cross-sectional
studies. The following characteristics were extracted from
each study included:
a) Administrative details: identification; author(s); pub-
lished or unpublished; year of publication; year in which
study was conducted; details of other relevant papers
cited.
b) Details of study: study design; method(s) of recruit-
ment; inclusion and exclusion criteria; number of partici-
pants assessed for eligibility, number excluded, number
enrolled, number analyzed; type, duration, frequency and
completeness of follow-up in the case of cohort studies;
country and location of the study.
c) Characteristics of participants: age; location; details of
intervention.
d) Crude and adjusted measures of effect, confidence
intervals and p-values were extracted. When an adjusted
analysis was performed, type of analysis and the list of
covariates adjusted for were recorded.BMC Pediatrics 2007, 7:15 http://www.biomedcentral.com/1471-2431/7/15
Page 3 of 9
(page number not for citation purposes)
e) The amount of maternal calcium intake was extracted
and reported as the amount of elemental calcium in mg.
Details of analysis
One study [12] did not report regression coefficients, but
reported the correlation coefficient between maternal cal-
cium intake and offspring blood pressure. Standard errors
for the correlation coefficients were computed using the
Fisher r-to-z transformation [13]. The correlation coeffi-
cients were transformed to standardized mean differences
and multiplied by blood pressure standard deviation to
estimate the effect [14].
The meta-analysis was conducted using the Revman com-
puter software package [15]. The amount of heterogeneity
between studies was assessed by a formal statistical test
(chi-square test), and by I2 [16]. The chi-squared test
assesses whether observed differences between results are
compatible with chance alone [17]. A low p-value pro-
vides evidence of heterogeneity of treatment effects [17].
The results of the chi-squared test might be misleading
because it has low power for trials with small sample size,
and I2 has been proposed as an additional tool for assess-
ing heterogeneity [16]. I2 describes the percentage varia-
bility in effect estimates that is due to heterogeneity rather
than sampling error (chance) and is not affected by the
number of trials in the meta-analysis [17]. A value greater
than 50% may be considered substantial heterogeneity.
Mathematically, it is defined as I2 = [(Q - df)/Q] × 100%,
where Q is the chi-squared statistic and df is the number
of degrees of freedom [18,19].
Quality assessment
Quality of randomized controlled trials was assessed fol-
lowing the method described in the Cochrane Collabora-
tion Handbook [17]. For observational studies, quality
was assessed following the recommendations of the Meta-
analysis of Observational Studies in Epidemiology
(MOOSE) guidelines [20].
Results
Two randomized trials [21,22] and three observational
studies [12,23,24] were included in the review. Three
studies included infants less than one year of age
[12,22,23] and four included children between 1 year and
9 years of age [12,21,22,24]. Table 1 describes the charac-
teristics of the two randomized trials. Both studies were
long-term follow-ups of randomized trials of calcium sup-
plementation during pregnancy to prevent pre-eclampsia.
In both studies the randomization procedure was ade-
quate, subject and health professionals were blinded
regarding calcium or placebo status, and baseline charac-
teristics were similar between study arms. Belizan et al.
[25] randomized 1194 women during early pregnancy to
either 2000 grams of oral calcium supplementation or
placebo. This study included only healthy primiparous
women. Compliance with calcium supplementation was
acceptable (more than 80%), and increased calcium
intake in the intervention group was confirmed by meas-
urements of urinary calcium excretion. A follow-up of this
experimental cohort was conducted 7 years after the orig-
inal trial [21]. The original study was conducted in three
hospitals, two public and one private, but the follow-up
only included the 614 participants from the private hospi-
tal (approximately 50% of the original sample). Rand-
omization was stratified by center, and the baseline
characteristics of those included in the follow-up were
comparable between the trial arms. However, women
excluded from the follow-up were younger and had lower
socioeconomic status than those included. Loss to follow-
up (16%) was acceptable for a long-term follow-up. This
study used cut-off points for systolic and diastolic pres-
sure, specific for sex, age and height, that corresponded to
the 95th centiles given in tables developed by the US
National Institutes of Health.
Hatton et al. [22] randomized 4,589 women during early
pregnancy to either 2000 grams of oral calcium supple-
mentation or placebo. A detailed clinical and laboratory
evaluation was conducted before trial entry, and women
with complications during pregnancy or signs or history
of calcium metabolism disorders were excluded. Further-
more, a baseline compliance test was used to exclude
women with low compliance before trial entry. Two fol-
low-up studies were conducted at 3 and 24 months post-
partum. Patients from only one out of five medical centers
were included in the follow-up (559 out 4589 subjects).
Randomization was stratified by center, but no data are
available on the baseline characteristics of the follow-up
sample. Loss to follow-up was 53% at 3 months and 90%
at 2 years. The authors acknowledge this to be a problem,
adding that that a large proportion of the cohort had not
reached two years of age by the end of the study. This is
the main methodological limitation of this study. Sample
size is also an issue, given the small number remaining for
analysis. Calcium intake from other sources (i.e. prenatal
supplements, diet) in the population from Belizan et al.
[25] was estimated at 600 mg per day, well below the rec-
ommended level during pregnancy. In contrast, the
reported calcium intake for the population in Hatton et al.
[22] was over 1200 mg per day, within recommended lev-
els. In summary, the two randomized trials included
[21,22] were similar in respect of the characteristics of the
intervention, study design and inclusion criteria, but dif-
fered in an important population characteristic (baseline
calcium intake); also, loss to follow-up was a problem in
one study [22].
Table 2 describes the characteristics of the three observa-
tional studies included in the review [12,23,24].BMC Pediatrics 2007, 7:15 http://www.biomedcentral.com/1471-2431/7/15
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McGarvey et al. [12] designed their study to explore the
association between infant blood pressure and maternal
dietary intake of calcium, potassium and magnesium.
Data on maternal prenatal diet were obtained by conduct-
ing a post-partum 116-item semi-quantitative food fre-
quency questionnaire (FFQ). The authors measured the
offspring blood pressure in hospital when the babies were
2–4 days old, and at home at 1, 6 and 12 months.
Gillman et al. [23] used the data from a cohort study of
pregnant women conducted in the US. This study was
designed to assess the effects of mother's diet on mother's
and offspring's health. It assessed maternal calcium intake
during the first and second trimesters using a validated
semi-quantitative FFQ, and measured offspring blood
pressure at birth and at 6 months. The authors reported
figures for calcium from food sources and from prenatal
supplements, and then performed two independent anal-
yses accordingly. This seems to have been a non-pre-spec-
ified analysis. The strength of the evidence for this analysis
is not clear because it was not stated whether this analysis
strategy was pre-specified [26].
Morley et al. [24] used the data from a population-based
survey in Tasmania designed to investigate sudden infant
death syndrome. Mothers of all live-born twins during the
study period were approached after birth for data collec-
tion, including nutritional supplement consumption dur-
ing pregnancy. Data on calcium consumption from other
sources (i.e. foods) were not available. Children were
assessed at a mean age of 9 years and blood pressure was
measured.
All three studies were conducted in developed countries,
and average calcium intake was higher than the recom-
mended calcium intake during pregnancy for the two
studies with quantitative estimates [12,23].
It is not clear whether outcome assessment in any of the
three observational studies was blinded to levels of expo-
sure. Loss to follow-up was large (see table 2 for details).
One of the studies [12] conducted follow-ups at 4 time
points, but the sample size decreased for older infants.
Less than 40% of the sample was available in the last fol-
low-up at 1 year of age. The authors reported that one of
Table 1: Characteristics of randomized controlled trials included in the review.
Belizan, 1997 Hatton, 2003
Methods
Randomization Numbered, sealed opaque envelopes, containing 
randomization codes.
Numbered treatment packs in computer-generated simple randomization 
sequence.
Lost to follow-up – women Of 593 (calcium) vs. 601 (placebo) enrolled, 14 vs. 13 
were lost before starting treatment and excluded from 
analysis; 577 vs. 588 had at least partial follow up. 
Follow up was incomplete for 52 vs. 46, but delivery 
data were available in 17 vs. 12 of these, giving delivery 
data for 544 vs. 554.
calcium 132/2,295 vs. placebo 121/2,294.
Lost to follow-up – offspring Of 614 randomized in one center (calcium 309/placebo 
305), 301/299 completed the first study, 2/6 infant 
deaths and 1/0 maternal deaths had occurred, leaving 
298/293 eligible for follow up. 289/285 were contacted, 
10/5 refused to participate, 22/19 lived outside the 
country, and 257/261 were assessed.
559 randomized in study site. Of 497 invited to participate in the follow-up 
study, BP was measured in 260 infants at 3 months of age and 57 toddlers at 2 
years of age.
Participants
Mothers Nulliparous women, < 20 weeks pregnant; blood 
pressure < 140/90 mmHg (mean of 5 measurements); 
no present or past disease; not taking medication; 
normal oral glucose tolerance tests.
Pregnant nulliparas (45% black, 35% non-Hispanic white, 17% Hispanic white). 
Passed compliance test (took 75% of placebo over 6–14 days); BP 134/84 
mmHg or less; urine protein dipstick negative or trace; 13–21 weeks pregnant.
Exclusion criteria: taking medications; obstetric or pre-existing diseases or 
personal characteristics which could influence study end-points, absorption or 
metabolism of calcium; any risk associated with calcium supplementation, or 
compliance; elevated serum creatinine (1.0 mg per decilitre or more) or calcium 
(10.6 mg per decilitre or more); renal disease; haematuria; history or family 
history of urolithiasis; frequent use of calcium supplements or antacids.
Of 11,959 women screened, 5,703 excluded initially and a further 1,667 after 
the compliance test. The remaining 4,589 women were enrolled.
Offspring Two public and one private hospital participated in the 
original trial, but only babies born in the private hospital 
were included in the follow-up study at 7 years of age.
Five participating medical centers participated in the original trial, but only 
babies born in one center (Oregon) were included in the follow-up study. 
Additional criteria for inclusion: mothers who completed the original trial, 
delivered an infant without serious problems, and who read english. Follow-up 
was completed at 12 week postpartum and at 2 years of age.
Interventions 2 g calcium as 500 mg calcium carbonate tablets, vs. 
identical looking placebo tablets. Compliance was 84% 
(calcium) and 86% (placebo).
2 g/day elemental calcium as calcium carbonate, or placebo. Taken until 
delivery, development of pre-eclampsia or suspicion of urolithiasis. All women 
took 50 mg calcium per day as normal supplementation and were asked to 
drink 6 glasses of water per day.
Compliance was 64% in the calcium group and 67% in the placebo group. 20% 
of women took > 90% of the allocated treatment.
Outcomes Systolic blood pressure, diastolic blood pressure, kidney 
stones, gall stones, hospital admissions
Systolic blood pressure, left ventricular wall mass. Diastolic blood pressure was 
measured at 2 years but group means were not reported.
Allocation Concealment AABMC Pediatrics 2007, 7:15 http://www.biomedcentral.com/1471-2431/7/15
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the primary reasons for the decrease in sample size with
age was that not all infants had reached 1 year by the end
of the study.
All three observational studies attempted to adjust for
confounding variables, but they differed markedly in the
set of variables included. Two of them adjusted for blood
pressure measurement conditions [12,23]. All three
adjusted for socioeconomic factors (e.g. maternal educa-
tion) and child age at assessment. One [12] reported esti-
mates from more than one model, including one adjusted
for dietary potassium and magnesium. Crude and
adjusted estimates were similar in all three studies, sug-
gesting that confounding was not a problem in exploring
this association.
A funnel plot was produced to assess publication bias
[27]. Because of the small number of studies, the figure
was not very informative and was not included in this
report. Publication bias cannot be excluded.
In summary, all five studies seem to have been well con-
ducted. The main limitation in all the observational stud-
ies was loss to follow-up. For two of these studies, small
sample size was also a problem. In one study, the focus of
the analysis was a sub-group analysis.
Higher maternal calcium intake during pregnancy was
associated with lower offspring systolic blood pressure in
all studies, but the effect was statistically significant in
only 3 of them [12,22,23] (see figure 1). There was heter-
ogeneity between studies (I2 > 50%); this was large for
studies conducted on children below 12 months of age
(I2 = 53%), and small for studies on older children (I2 <
10%). Because of this heterogeneity, the analysis was
stratified according to age, and a summary measure
(meta-analysis) was obtained only for studies that
reported on children aged 1 year or more. The results of
this analysis are compatible with a reduction in SBP in the
calcium group of -1.92 mm Hg (95% CI -3.14 to -0.71)
(see figure 1).
In the largest randomized trial [21] there was a modest,
statistically insignificant effect on systolic blood pressure,
but a clinically and statistically significant effect on the
incidence of high systolic blood pressure at 7 years of age
(see table 3). This study also reported that the effect is
stronger among overweight children; this was not
Table 2: Characteristics of observational studies included in the review.
McGarvey, 1990 Gillman, 2004 Morley, 2004
Country, region Rhode Island, USA Massachusetts, USA Tasmania, Australia
Age at Follow-up At birth – 1 month – 6 month – 12 month 6 month 9 years
Sample size 212 – 184 – 114 – 70 936 294
Outcome measures Systolic and diastolic blood pressure Systolic blood pressure Systolic and diastolic blood pressure, 
insulin, fasting glucose, triacylglicerol, 
cholesterol (total, HDL and LDL)
Average maternal calcium 
intake during pregnancy (mg/
day)
1712 Total:1494 first trimester (FT), 1330 
second trimester (ST). From prenatal 
supplements: 264 (FT), 203 (ST). From 
food: 1230 (FT), 1128 (ST).
NA
Exposure measurement Maternal prenatal diet assessed postpartum in 
hospital by a 116 item semi quantitative food 
frequency questionnaire.
Maternal diet assessment with a semi 
quantitative food frequency questionnaire 
validated in pregnancy during the first 
trimester and second trimester. Analysis 
stratified by calcium from food and 
calcium from prenatal supplements.
Mothers of all live born twins in 
Tasmania were approached soon after 
birth. They were asked whether they had 
taken any nutritional supplements during 
pregnancy.
Exposure categories, maternal 
calcium intake in mg
Quartiles (1380, 1722, 2048) and correlation 
coefficients
Quartiles (Q4 - Q1 = 424 mg) and linear 
regression
Maternal calcium supplements during 
pregnancy (yes/no). Calcium content of 
supplements not stated.
Blinding of exposure status and 
ascertainment of outcome.
Unknown Unknown Unknown
Lost to follow-up or invalid 
exclusions
Total eligible population not stated. 212 
mothers with prenatal dietary data included. 
Lost to follow-up by age at follow-up (%): 0 
13 46 67
2128 total population. 462 missing 
maternal diet assessment, 232 did not 
consent, 381 did not attend follow-up 
visits, 77 outcome missing, 39 missing 
covariates.
Total eligible population not stated. 463 
twin children recruited. 11had co-twin 
not available for recruitment. 23 pairs 
left Tasmania. 14 pairs could not be 
traced and 42 declined to participate.
Adjustment Cuff size, observer, sleep/activity status. Age 
in days (At birth), body weight (at 6 and 12 
month). Maternal race, parents education and 
occupation. Dietary potassium and 
magnesium
Energy intake, BP measurement 
conditions (cuff size, infant position, 
appendage used, machine model, infant 
state, clinic site)
Maternal age and education, twin pair 
birth order (in family), child age at 
assessment and sex. Study in twins.
Maternal race, education, number of 
previous pregnancies, marital status, 
pregnancy body mass index and third 
trimester systolic blood pressure. Infant 
age and sex.
Comments Study reported two sets of results, for 
calcium from food and from prenatal 
supplements.
Study in twins.BMC Pediatrics 2007, 7:15 http://www.biomedcentral.com/1471-2431/7/15
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Table 3: Maternal calcium intake during pregnancy and blood pressure in the offspring. Summary of results from the long term follow-
up of randomized controlled trials.
Outcome measure Age at follow-up calcium placebo Mean Difference (95%CI) p value
Nm e a nNm e a n
Systolic Blood Pressure (mm Hg)
Belizan 1997 7 years 257 103.9 (10.6) 261 105.3 (11.0) -1.4 (-3.2 to 0.5) 0.14
Hatton 2003 2 years 35 95.4 (7.6) 18 100.2 (7.9) -4.8 (-9.2 to -0.3) 0.036
Hatton 2003 3 month 130 111.4 (14.3) 130 113.6 (12.6) -2.2 (-5.5 to 1.1) 0.20
Diastolic Blood Pressure (mm Hg)
Belizan 1997 7 years 257 65.4 (9.3) 261 65.8 (9.3) -0.4 (-2.0 to 1.2) 0.63
n/N (%) n/N (%) Relative Risk (95%CI)
High Blood Pressure – systolic
Belizan 1997 7 years 29/257 (11.4) 50/261 (19.3) 0.59 (0.39 to 0.90) 0.01
High Blood Pressure – diastolic
Belizan 1997 7 years 26/257 (10.2) 33/261 (12.7) 0.80 (0.49 to 1.30) 0.41
Maternal calcium supplementation during pregnancy and offspring systolic blood pressure, by offspring age at follow-up Figure 1
Maternal calcium supplementation during pregnancy and offspring systolic blood pressure, by offspring age at follow-up. Key: 
Calcium source: F from food, S from supplements. RCT, Randomized Controlled Trial. Lines are 95% confidence intervals. 
Boxes are proportional to the sample size of the trial.
Study Effect size and 95% CI
McGarvey (1990) At birth
McGarvey (1990) 1 month
McGarvey (1990) 6 month
Hatton (2003) 6 month
Gillman (2004) 6 month
Gillman (2004) 6 month
McGarvey (1990) 12 month
Hatton (2003) 2 years
Belizan (1997) 7 years
Morley (2004) 9 years
-6 0
Systolic blood pressure (mm Hg)
-9 -3 3
Age less than 12 month
Age 12 month or more



























































































































































Table 4: Maternal calcium intake during pregnancy and blood pressure in the offspring. Summary of results from observational studies.




N Offspring blood pressure in mm Hg, by quartiles 
of maternal calcium intake
Crude effect size 
(95%CI)‡
p value Adjusted effect size 
(95% CI)*
p value
low med-low med-high high
Systolic blood pressure (mm Hg)
McGarvey 1990 At Birth F+S 1712 212 71.5 70.8 70.2 69.9 -0.84 (-3.69 to 2.01) 0.56 NA
McGarvey 1990 1 month F+S 1712 184 82.4 81.8 77.9 75.5 -6.13 (-9.32 to -2.94) < 0.01 -4.28 (-7.12 to -1.44) < 0.01
McGarvey 1990 6 month F+S 1712 114 87.0 85.7 83.5 84.1 -3.84 (-7.81 to 0.13) 0.06 -3.08 (-6.66 to 0.50) 0.08
6 month F 91.5 90.2 90.4 88.4 -0.30 (-1.29 to 0.69) 0.55 -0.04 (-1.10 to 1.00) 0.55
Gillman 2004 6 month S 1494 936 91.1 90.3 91 90.3 -3.10 (-4.78 to -1.42) < 0.01 -3.00 (-4.90 to -1.10) < 0.01
McGarvey 1990 12 month F+S 1712 70 89.6 85.8 85.3 86.2 -4.28 (-8.94 to 0.38) 0.72 -3.40 (-8.40 to 1.69) 0.14
Morley 2004 9 years S NA 294 96.4 95.6 -0.80 (-4.17 to 2.57) 0.64 -0.70 (-4.20 to 2.70) 0.70
Diastolic blood pressure (mm Hg)
McGarvey 1990 At Birth F+S 1712 212 42.1 42.6 41.8 41.7 0.21 (-2.64 to 3.06) 0.88 NA
McGarvey 1990 1 month F+S 1712 184 41.0 43.1 41.2 40.9 -0.95 (-3.72 to 1.82) 0.50 -1.91 (-4.96 to 0.87) 0.18
McGarvey 1990 6 month F+S 1712 114 56.9 51.9 48.6 50.3 -5.89 (-9.95 to -1.83) < 0.01 -4.28 (-7.90 to -0.66) 0.01
McGarvey 1990 12 month F+S 1712 70 53.1 49.1 47.6 49.7 -4.80 (-9.39 to -0.01) 0.05 -5.19 (-10.37 to 0.01) 0.07
Morley 2004 9 years S NA 294 52.6 51.8 -0.80 (-2.80 to 1.20) 0.40 -0.90 (-2.90 to 1.10) 0.40
‡ Regression coefficient between maternal calcium intake and blood pressure.
* See table 2 for the list of variables of variables included in the models for each study.
† F calcium from food sources, S calcium from supplements.BMC Pediatrics 2007, 7:15 http://www.biomedcentral.com/1471-2431/7/15
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observed by others, though the sample sizes were too
small to exclude such a difference.
For children under 12 months, the data are less consistent
(see table 4). In the same cohort, one study [12] found no
effect at birth, a strong effect at 1 month and a moderate
effect at 6 months. Another [23] reported that no effect
was associated with calcium from foods, but a strong
effect was found in association with (prenatal) calcium
supplements. This analysis strategy did not seem to be
pre-specified, and the authors failed to provide a convinc-
ing hypothesis to account for the finding. Finally, the fol-
low-up at 3 months conducted by Hatton et al. [22] was
too small to draw any conclusion.
Discussion
This systematic review of the literature identified two ran-
domized trials and three observational studies. The evi-
dence provided by this body of research suggests an
association between dietary calcium intake during preg-
nancy and offspring blood pressure. A good quality rand-
omized trial found a large reduction in the incidence of
hypertension in children at 7 years of age [21]. However,
the same trial found a smaller effect on blood pressure as
a continuous variable. A possible explanation for these
findings is that the intervention produced a change in the
shape of the blood pressure distribution, as opposed to a
shift in mean blood pressure.
A meta-analysis that combined four studies on children
over one year of age found a reduction in mean systolic
blood pressure. This finding should be viewed with cau-
tion, since evidence obtained by combining small studies
has previously been shown to be unreliable because of
publication bias [28]. For infants under one year of age
the evidence is contradictory and difficult to summarize.
Among the 5 studies reported, only two were randomized
trials. The validity of the evidence from observational
studies for assessing the effect of interventions is contro-
versial [17]. The two randomized trials included in the
review were multi-center trials and the randomization was
stratified by center. The authors chose to follow up sub-
jects from only one center. It can be assumed that because
the randomization was stratified by center, the effect esti-
mate will not be biased. However, an impact on external
validity can be expected. For example, in one study, par-
ticipants from the selected hospital were of higher socioe-
conomic status than those from the centers not included
in the follow-up [21]. Apart for the methodological prob-
lems of the original articles, other limitations of this anal-
ysis should be pointed out. Four out of the five studies
included in the review were conducted in developed
countries, and on populations in which maternal calcium
intake was adequate or even higher than the recom-
mended levels during pregnancy. This is clearly not the
ideal target for a nutritional intervention. Given the evi-
dence that the effect of calcium might be apparent only
when there is a deficit, the external validity of these results
might be compromised [5].
The heterogeneity between studies also creates difficulties
for interpreting the results. The sources and dose of dietary
calcium vary widely among the observational studies, and
so do the methods used to assess the amount consumed.
There are also large differences between studies in infants'
ages at assessment. It is well known that the determinant
of blood pressure varies with age, and it has been shown
that the impact of factors affecting the fetal environment
are seen particularly after adolescence [29]. This problem
is magnified because of the difficulties in measuring
blood pressure accurately at early ages [30].
Conclusion
In summary, there is evidence in the literature to support
an association between maternal calcium intake during
pregnancy and offspring blood pressure. However, more
research is needed to confirm these findings, given the
small sample sizes and the methodological problems of
many of the studies conducted so far. New evidence
should be derived from the long-term follow-up of large
and well-conducted randomized trials of calcium supple-
mentation during pregnancy. More studies on popula-
tions with calcium intake deficit are also needed.
Assessing the effect of the intervention on other cardiovas-
cular risk factors would also be an asset for future research.
Calcium supplementation during pregnancy is simple
and inexpensive, and if these findings are confirmed it
could be a way to prevent hypertension and its sequels in
the next generation.
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